Jeremy Grushcow

Biography

Jeremy Grushcow's practice focuses on life science, cleantech and other technology-intensive transactions. He has represented private equity firms, investment banks, operating companies and founders in connection with public and private offerings, mergers and acquisitions, joint ventures and other strategic transactions, licensing and outsourcing agreements, operating and service agreements and ongoing disclosure advice.

Mr. Grushcow blogs at The Cross-Border Biotech Blog.

Prior to joining the firm, Mr. Grushcow practised in the area of intellectual property transactions and in capital markets at two US-based international law firms.

Year of Call

• Ontario Bar 2009
• New York Bar 2006
• Illinois Bar 2003

Law School

• J.D. (Hons.), University of Chicago Law School, 2003

EDUCATION

• Ph.D., Molecular Genetics and Cell Biology, University of Chicago, 2000
• B.Sc., Human Biology, University of Toronto, 1995

Selected Client Work

Mr. Grushcow has recently acted for the following clients:

• OMERS, a Canadian pension fund, in connection with a unique joint venture with Dutch pension fund ABP to establish an investment program to deploy €200 million in Canada and the Netherlands over the first five years to invest in knowledge economy start-ups with innovative ideas and technologies
• Bioniche Life Sciences and Bioniche Urology in connection with the US licence, development and supply agreement with Endo Pharmaceuticals for Bioniche's lead drug candidate Urocidin^TM, a mycobacterial cell wall-DNA complex which Bioniche Life Sciences developed and owns

Publications

LAW

• "FINRA Proposes New Registration Category for Investment Bankers," Information bulletin, Ogilvy Renault, April 2009.
• "Passage of Genetic Information Nondiscrimination Act (GINA) in the U.S. Opens the Door for Personalized Medicine,"Information bulletin, Ogilvy Renault, May 2008.
• "No Copies? No Index? No Problem. Poster Presentations can be Printed Publications Anyway," Kirkland & Ellis LLP Biotech Update, Spring 2005.
• "Measuring Secrecy: A Cost of the Patent System Revealed," J. Legal Studies, No. 33, p. 59, 2004.
• "The Ethics of Subject Selection for the Testing of Live-Attenuated HIV Vaccines," 6 U. Chi. L. Sch. Roundtable 113, 1999.

SCIENCE

• Mr. Grushcow blogs at The Cross-Border Biotech Blog.
• "Mitotic Phosphorylation of Histone H3 is Governed by Ipl1/aurora Kinase and Glc7/PP1 Phosphatase in Budding Yeast and Nematodes"(co-authors: Jer-Yuan Hsu, Zu-Wen Sun, Xiumin Li, Melanie Reuben, Kelly Tatchell, Douglas K. Bishop, Cynthia J. Brame, Jennifer A. Caldwell, Donald F. Hunt, Rueyling Lin, M. Mitchell Smith and C. David Allis), 102 Cell 279, 2000.
• "S. cerevisiae Checkpoint Genes MEC1, RAD17, and RAD24 are Required for Normal Meiotic Recombination Partner Choice and Synapsis" (co-authors: Teresa M. Holzen, Ken J. Park, Ted Weinert, Michael Lichten and Douglas K. Bishop), 153 Genetics 607, 1999.
• "Gene Therapy Strategies for Carcinoma of the Breast" (co-authors: J.M. Ruppert, M. Wright, M. Rosenfeld, G. Bilbao, D.T. Curiel and T.V. Strong), 44 Breast Cancer Research and Treatment 93, 1997.
• "Synthesis of Di- and Tri-Saccharides with Intramolecular NH-glycosidic Linkages: Molecules with Flexible and Rigid Glycosidic Bonds for Conformational Studies" (co-authors: Jacqueline Goddat, Arthur A. Grey, Milos Hricovini, Jeremy P. Carver and Rajan N. Shah), 252 Carbohydrate Research,159, 1994.

Speaking Engagements

• "Licensing and Strategic Partnerships" (co-presenter: Christopher Hunter), Growing Your Business, R.I.C. and OCETA, Toronto: May 2009.
• "Public Market Strategies for Cleantech Investing" (Panelist), BioFinance 2009, Toronto: April 2009.
• Workshop: "Negotiating and Drafting Performance Warranties and Guarantees" (co-instructor: Robert Percival), Negotiating and Drafting IT Agreements, Osgoode Professional Development, February 2009.
• "IP Holding Companies and Lost Profits" (co-presenter: Lesley Smith), Intellectual Property Group Transactional Training, Kirkland & Ellis LLP, January 2005.
• "Fieldturf v. SRI: Standing to Sue in Patent License Agreements" (co-presenter: Michael G. Fatall), Intellectual Property Group Transactional Training, Kirkland & Ellis LLP, June 2004.

Media Highlights

• "Les avocats, ces nouveaux blogueurs," Les Affaires, January 6, 2010.
• "Tentative Steps Into The Blogosphere," Globe and Mail, January 6, 2010.
• "Law Firms Test Potential for Social Media," Lexpert / Globe and Mail, November 18, 2009.
• "Horizon Issues: Life Sciences," Counsel to Counsel, September 30, 2009.

Rankings and Recognitions

University of Chicago Law School

• John M. Olin Prize - Outstanding Graduate in Law and Economics (2003) 
• Order of the Coif (2003) 
• Nierman Scholar (2002-2003) 
• Bradley Student Fellow (2002-2003) 
• Yee Scholar (2001-2002) 
• Olin Fellow (2001-2002) 

University of Chicago Division of Biological Sciences

• University of Chicago Biological Sciences Student Teaching Prize (1997)                      

University of Toronto

• Institute of Medical Sciences Summer Undergraduate Research Fellow (1994 and 1995)

Memberships and Activities

• Mr. Grushcow blogs at The Cross-Border Biotech Blog.
• Genetics Society of America
• American Association for the Advancement of Science
• University of Chicago Law Review Staff, 2001-2003 
• University of Chicago Intellectual Property Law Society
  • President (2002-2003)
  • Board Member (2001-2002)